Stilla Technologies
Latest round
- Series B
Last raised
- Dec 2019
Total raised
- $19M
Investors
- 7
About Stilla Technologies
Founded in 2013 in Paris, France, Stilla Technologies SAS focuses on digital PCR solutions, including its flagship Nio® platform. The founders, Charles Baroud and Clément Gay, have a history of entrepreneurship in tech and biotech sectors, contributing to the company’s innovative approach.Stilla Technologies specializes in advanced digital polymerase chain reaction (dPCR) solutions through its flagship product, the Nio® system, which enables accurate DNA quantification across various applications, including oncology and pathogen detection. The Nio® platform is capable of processing up to 768 samples in an 8-hour workday, with user-friendly software and continuous loading capabilities.10 with an EBITDA of EUR -13,362,308. The company earns revenue through direct sales of the Nio® digital PCR systems, consumables, and specialized assay kits to academic institutions and biotech firms, establishing a strong B2B framework. The company plans to introduce new products into the market and enhance its presence in existing and new geographic regions. Specific markets targeted for expansion include North America and Asia, with plans to solidify their impact by 2023.
Who invested in Stilla Technologies
7 investors across 2 rounds
See all investors in Stilla Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Stilla Technologies
Who invested in Stilla Technologies?
Stilla Technologies has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stilla Technologies raised?
Stilla Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Stilla Technologies last raise money?
Stilla Technologies's most recent round on record is a Series B, in Dec 2019.
What does Stilla Technologies do?
Founded in 2013 in Paris, France, Stilla Technologies SAS focuses on digital PCR solutions, including its flagship Nio® platform.
Where is Stilla Technologies headquartered?
Stilla Technologies is headquartered in Paris, France.
Which VCs invest in companies like Stilla Technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Stilla Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Stilla Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.